Clinical Trial Update: CellFX® Nanosecond Pulsed Field Ablation (PFA) 360 Catheter Ablation System for Treatment of Atrial Fibrillation [NA]

View source ↗

Summary

Ongoing clinical trial evaluating the CellFX Nanosecond Pulsed Field Ablation (PFA) 360 Catheter Ablation System for treating atrial fibrillation; the study sta…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation
• Cardiac Arrhythmia

Drugs mentioned

• CellFX Nanosecond Pulsed Field Ablation (PFA) 360 Catheter Ablation System

Snippet

Sponsor: Pulse Biosciences, Inc. | Conditions: Atrial Fibrillation Paroxysmal, Cardiac Ablation | NA | Status: RECRUITING